These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 12627509)

  • 1. Down-regulation of fragile histidine triad expression in prostate carcinoma.
    Fouts RL; Sandusky GE; Zhang S; Eckert GJ; Koch MO; Ulbright TM; Eble JN; Cheng L
    Cancer; 2003 Mar; 97(6):1447-52. PubMed ID: 12627509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The fragile genes FHIT and WWOX are inactivated coordinately in invasive breast carcinoma.
    Guler G; Uner A; Guler N; Han SY; Iliopoulos D; Hauck WW; McCue P; Huebner K
    Cancer; 2004 Apr; 100(8):1605-14. PubMed ID: 15073846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The methylation status and protein expression of CDH1, p16(INK4A), and fragile histidine triad in nonsmall cell lung carcinoma: epigenetic silencing, clinical features, and prognostic significance.
    Nakata S; Sugio K; Uramoto H; Oyama T; Hanagiri T; Morita M; Yasumoto K
    Cancer; 2006 May; 106(10):2190-9. PubMed ID: 16598757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathological significance of fragile histidine triad transcription protein expression in breast carcinoma.
    Yang Q; Yoshimura G; Suzuma T; Tamaki T; Umemura T; Nakamura M; Nakamura Y; Wang X; Mori I; Sakurai T; Kakudo K
    Clin Cancer Res; 2001 Dec; 7(12):3869-73. PubMed ID: 11751477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fhit expression in gastric adenocarcinoma: correlation with disease stage and survival.
    Capuzzi D; Santoro E; Hauck WW; Kovatich AJ; Rosato FE; Baffa R; Huebner K; McCue PA
    Cancer; 2000 Jan; 88(1):24-34. PubMed ID: 10618602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of FHIT expression in cervical carcinoma cell lines and primary tumors.
    Greenspan DL; Connolly DC; Wu R; Lei RY; Vogelstein JT; Kim YT; Mok JE; Muñoz N; Bosch FX; Shah K; Cho KR
    Cancer Res; 1997 Nov; 57(21):4692-8. PubMed ID: 9354423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fragile histidine triad gene abnormalities in the pathogenesis of gallbladder carcinoma.
    Wistuba II; Ashfaq R; Maitra A; Alvarez H; Riquelme E; Gazdar AF
    Am J Pathol; 2002 Jun; 160(6):2073-9. PubMed ID: 12057912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Abnormal expression of fragile histidine triad (FHIT) and Mut S homolog 2 (MSH2) proteins in human sporadic colorectal carcinoma and their clinical significance].
    Yao CC; Lin CY; Hu MB
    Ai Zheng; 2004 Mar; 23(3):310-6. PubMed ID: 15025965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Loss of fragile histidine triad expression and metastasis in breast cancer].
    Zhao P; Li XY; Chen LZ
    Ai Zheng; 2002 Jun; 21(6):668-70. PubMed ID: 12452072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The expression of Fhit protein is related inversely to disease progression in patients with breast carcinoma.
    Gatalica Z; Lele SM; Rampy BA; Norris BA
    Cancer; 2000 Mar; 88(6):1378-83. PubMed ID: 10717620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inactivation of the human fragile histidine triad gene at 3p14.2 in monochromosomal human/mouse microcell hybrid-derived severe combined immunodeficient mouse tumors.
    Kholodnyuk ID; Szeles A; Yang Y; Klein G; Imreh S
    Cancer Res; 2000 Dec; 60(24):7119-25. PubMed ID: 11156420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of fragile histidine triad expression in tumors from saudi arabia: a tissue microarray analysis.
    Bavi P; Jehan Z; Atizado V; Al-Dossari H; Al-Dayel F; Tulbah A; Amr SS; Sheikh SS; Ezzat A; El-Solh H; Uddin S; Al-Kuraya K
    Cancer Epidemiol Biomarkers Prev; 2006 Sep; 15(9):1708-18. PubMed ID: 16985034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alterations of the FHIT gene in human hepatocellular carcinoma.
    Yuan BZ; Keck-Waggoner C; Zimonjic DB; Thorgeirsson SS; Popescu NC
    Cancer Res; 2000 Feb; 60(4):1049-53. PubMed ID: 10706123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Correlation of FHIT expression to cell proliferation and metastasis of laryngeal squamous cell carcinoma].
    Yin DT; Lu XB; Dong MM; Qiu XG; Wang QZ
    Ai Zheng; 2004 Nov; 23(11):1338-41. PubMed ID: 15522186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Fragile histidine triad expression in rhabdomyosarcoma].
    Wang SL; Yang GH; Bu H; Guo LX; Zhou Q; Zhang HY; Ye L
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Mar; 35(2):176-8. PubMed ID: 15071908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential susceptibility of renal carcinoma cell lines to tumor suppression by exogenous Fhit expression.
    Werner NS; Siprashvili Z; Fong LY; Marquitan G; Schröder JK; Bardenheuer W; Seeber S; Huebner K; Schütte J; Opalka B
    Cancer Res; 2000 Jun; 60(11):2780-5. PubMed ID: 10850413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormal fragile histidine triad (Fhit) expression in invasive cervical adenocarcinoma: association with tumor aggressiveness.
    Yoon SO
    Hum Pathol; 2007 Feb; 38(2):326-31. PubMed ID: 17137614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inverse correlation of aberrant expression of fragile histidine triad (FHIT) protein with cyclin D1 protein and prognosis in Chinese patients with cholangiocarcinoma.
    Zhao P; Lu Y; Zhong M; Liu L; Li B
    Acta Oncol; 2008; 47(8):1557-63. PubMed ID: 18618300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Allelic loss and down-regulation of FHIT gene expression in esophageal squamous cell carcinoma].
    Liu FX; Huang XP; Zhao CX; Xu X; Han YL; Cai Y; Wu RL; Wu M; Zhan QM; Wang MR
    Ai Zheng; 2004 Sep; 23(9):992-8. PubMed ID: 15363189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of fragile histidine triad gene expression in advanced lung cancer is consequent to allelic loss at 3p14 locus and promoter methylation.
    Wali A; Srinivasan R; Shabnam MS; Majumdar S; Joshi K; Behera D
    Mol Cancer Res; 2006 Feb; 4(2):93-9. PubMed ID: 16513840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.